Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.
The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov .
Updates regarding government operating status and resumption of normal operations can be found at OPM.gov .

Dr. Michael Opata

Dr. Michael Opata

Scientific Review Officer



Biography

Division:
Division of Translational and Clinical Sciences DTCS
Review Branch:
Cancer Therapeutics CTH

Dr. Michael Opata received his Ph.D. in microbiology, immunology, and molecular genetics from the University of Kentucky. He obtained postdoctoral training in infectious diseases from the University of Texas Medical Branch at Galveston. Dr. Opata then took a faculty position at Appalachian State University, where he served as an assistant and then an associate professor. The focus of his research lab and program was on how moderate malnutrition affects the survival of long-term memory CD4 T cells. He trained many undergraduate and graduate students and served as a reviewer for several journals, including Frontiers in Nutrition, Immunology and Infection, and Immunity. Prior to joining CSR, he was a scientific review officer at the National Institute of Allergy and Infectious Diseases (NIAID), where he oversaw special emphasis panels on vaccine adjuvants, solid organ transplantation, radiation, biodosimetry, and medical countermeasures, among others.

 

Last updated: 09/17/2025 13:48